Phenotypic variability of mitochondrial disease caused by a nuclear mutation in complex II-Reference-Cited by-同舟云学术

Phenotypic variability of mitochondrial disease caused by a nuclear mutation in complex II

Published:2006-11 Issue:3 Volume:89 Page:214-221
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Pagnamenta Alistair T.,Hargreaves Iain P.,Duncan Andrew J.,Taanman Jan-Willem,Heales Simon J.,Land John M.,Bitner-Glindzicz Maria,Leonard James V.,Rahman Shamima

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference28 articles.

1. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency;Bourgeron;Nat. Genet.,1995

2. Deficiency in complex II of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome;Bourgeois;Brain Dev.,1992

3. Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome;Parfait;Hum. Genet.,2000

4. Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene;Birch-Machin;Ann. Neurol.,2000

5. Deficiency of complex II of the mitochondrial respiratory chain in late-onset optic atrophy and ataxia;Taylor;Ann. Neurol.,1996

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-6-elicited chronic neuroinflammation may decrease survival but is not sufficient to drive disease progression in a mouse model of Leigh syndrome;Journal of Inflammation;2024-01-11

2. Structure of the human respiratory complex II;Proceedings of the National Academy of Sciences;2023-04-25

3. Inhibition of Succinate Dehydrogenase by Pesticides (SDHIs) and Energy Metabolism;International Journal of Molecular Sciences;2023-02-17

4. Leigh syndrome;Mitochondrial Diseases;2023

5. Mitochondrial protein dysfunction in pathogenesis of neurological diseases;Frontiers in Molecular Neuroscience;2022-09-07